Gut stem cell shot aims to reverse diabetes

NCT ID NCT07344324

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early study tests if injecting a person's own stem cells into the upper gut is safe and feasible for treating type 2 diabetes. The stem cells are taken from belly fat and processed before being injected during a scope procedure. Only 15 people will take part, and the main goal is to check for side effects, not to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
adipose-derived mesenchymal stem cells (ADMSCs)
What this could lead to
If it works, this could point toward a new way to improve insulin sensitivity and blood sugar control in type 2 diabetes, potentially reducing the need for medication.
What could go wrong
This is a very early, small pilot study (15 people) focused on safety, not effectiveness. The procedure is invasive and may cause side effects. Success is far from guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.